Bernhard Witzenbichler
#133,779
Most Influential Person Now
Researcher
Bernhard Witzenbichler's AcademicInfluence.com Rankings
Bernhard Witzenbichlercomputer-science Degrees
Computer Science
#6026
World Rank
#6355
Historical Rank
Machine Learning
#1820
World Rank
#1844
Historical Rank
Artificial Intelligence
#2069
World Rank
#2104
Historical Rank
Database
#3149
World Rank
#3283
Historical Rank
Download Badge
Computer Science
Why Is Bernhard Witzenbichler Influential?
(Suggest an Edit or Addition)Bernhard Witzenbichler's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Isolation of Putative Progenitor Endothelial Cells for Angiogenesis (1997) (8778)
- Bivalirudin during primary PCI in acute myocardial infarction. (2008) (1816)
- Incidence (1931) (868)
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study (2013) (734)
- Mouse model of angiogenesis. (1998) (730)
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI. (2019) (539)
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study (2013) (532)
- Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. (1998) (468)
- Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial (2011) (458)
- Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. (2009) (455)
- Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2* (1998) (450)
- Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. (2019) (435)
- Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial (2009) (408)
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. (2016) (406)
- Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. (2012) (402)
- Reciprocal relation between VEGF and NO in the regulation of endothelial integrity (1997) (373)
- Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. (1998) (365)
- Role of endothelial nitric oxide synthase in endothelial cell migration. (1999) (327)
- Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. (2015) (315)
- Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Study (2014) (284)
- Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. (1999) (277)
- Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. (2011) (260)
- Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study (2013) (224)
- Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach: A Retrospective and Prospective Study Analyzing 3048 Diagnostic Procedures Over an 11-Year Period (2008) (214)
- Protective Role of Angiopoietin-1 in Endotoxic Shock (2005) (209)
- Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. (2014) (209)
- Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. (2012) (207)
- Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. (1997) (207)
- Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction (2011) (190)
- Intravascular Ultrasound Findings of Early Stent Thrombosis After Primary Percutaneous Intervention in Acute Myocardial Infarction: A Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Substudy (2011) (185)
- Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: Results of the Randomized BIOFLOW-II Trial (2015) (176)
- Incidence, Mechanisms, Predictors, and Clinical Impact of Acute and Late Stent Malapposition After Primary Intervention in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HOR (2010) (167)
- Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. (2009) (159)
- Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention). (2015) (153)
- Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (137)
- Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials (2015) (128)
- Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (124)
- Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS‐AMI trial (2015) (109)
- When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. (2010) (107)
- The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (103)
- Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial. (2011) (102)
- Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2010) (98)
- Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. (1999) (97)
- Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions. (2016) (92)
- Self-expanding versus balloon-expandable stents in acute myocardial infarction: results from the APPOSITION II study: self-expanding stents in ST-segment elevation myocardial infarction. (2012) (88)
- Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. (1999) (82)
- The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial (2014) (81)
- Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. (2011) (77)
- Coronary Angiographic Findings in Acute Ischemic Stroke Patients With Elevated Cardiac Troponin: The Troponin Elevation in Acute Ischemic Stroke (TRELAS) Study. (2016) (73)
- Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial. (2013) (73)
- Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial). (2013) (70)
- Incidence, Predictors, and Implications of Reinfarction After Primary Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial (2014) (69)
- Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials. (2015) (68)
- Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. (2017) (67)
- Impact of Leukocyte Count on Mortality and Bleeding in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Interventions: Analysis From the Harmonizing Outcome With Revascularization and Stent in Acute Myocardial Infarction Trial (2011) (67)
- Ticagrelor With or Without Aspirin After Complex PCI (2020) (66)
- Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. (2020) (65)
- Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Registry (2015) (64)
- Intralesional Abciximab and Thrombus Aspiration in Patients With Large Anterior Myocardial Infarction: One-Year Results From the INFUSE-AMI Trial (2013) (58)
- Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction). (2014) (56)
- Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial. (2013) (54)
- Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial. (2013) (54)
- Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction: An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction). (2015) (54)
- Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Intravascular Ultrasound Substudy (2009) (53)
- Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial). (2013) (53)
- Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial (2021) (53)
- Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions. (2011) (52)
- A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study. (2010) (52)
- Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. (2012) (51)
- Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. (1999) (51)
- Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis. (2011) (51)
- Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials). (2011) (49)
- Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia may contribute to early contractile failure. (1994) (49)
- Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy). (2015) (48)
- Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial. (2010) (48)
- Body mass index and acute and long-term outcomes after acute myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). (2014) (48)
- Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. (2016) (47)
- Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure? (1995) (47)
- Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. (2013) (47)
- Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention. (2020) (47)
- Prevalence, Features, and Prognostic Importance of Edge Dissection After Drug-Eluting Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy (2016) (45)
- First-in-man (FIM) study of the Stentys bifurcation stent--30 days results. (2009) (45)
- D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy (2013) (44)
- Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. (2011) (42)
- Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study (2015) (41)
- Comparison of direct stenting with conventional stent implantation in acute myocardial infarction. (2011) (41)
- Troponin elevation in acute ischemic stroke (TRELAS) - protocol of a prospective observational trial (2011) (40)
- Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy. (2016) (40)
- B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction: A Substudy from the HORIZONS-AMI Trial (2012) (39)
- Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis. (2020) (39)
- Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. (2013) (38)
- Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation. (2018) (36)
- Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial). (2014) (36)
- Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy). (2012) (36)
- Takotsubo cardiomyopathy following ischemic stroke: a cause of troponin elevation (2011) (36)
- Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. (2020) (34)
- Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. (2013) (34)
- Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus. (2020) (33)
- Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial. (2013) (33)
- Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. (2016) (33)
- The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study. (2016) (33)
- Predictors and Long‐Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug‐Eluting Stents (ADAPT‐DES) Intravascular Ultrasound Substudy (2016) (32)
- Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2012) (32)
- Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy). (2013) (32)
- Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). (2015) (32)
- Coronary Angiographic Findings in Acute Ischemic Stroke Patients With Elevated Cardiac TroponinCLINICAL PERSPECTIVE (2016) (32)
- Percutaneous Coronary Intervention of Saphenous Vein Graft (2017) (32)
- Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials). (2017) (32)
- Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. (2011) (31)
- Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial). (2011) (31)
- Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes (2020) (29)
- Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. (2010) (29)
- Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. (2017) (29)
- Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry. (2014) (29)
- Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. (2013) (29)
- Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. (2021) (28)
- Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents) (2017) (27)
- Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention (2016) (27)
- Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. (2016) (25)
- Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). (2013) (25)
- White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry) (2017) (23)
- Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST‐segment elevation myocardial infarction: Results of the HORIZONS‐AMI trial (2015) (23)
- Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: Two-Year Follow-Up of the ADAPT-DES Study (2018) (23)
- Impact of Routine Invasive Physiology at Time of Angiography in Patients With Multivessel Coronary Artery Disease on Reclassification of Revascularization Strategy: Results From the DEFINE REAL Study. (2018) (22)
- Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) (2018) (21)
- Differences in Underlying Culprit Lesion Morphology Between Men and Women: An IVUS Analysis From the ADAPT-DES Study. (2016) (20)
- Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: Results from the INFUSE‐AMI study (2014) (20)
- Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial). (2010) (19)
- Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. (2016) (19)
- Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model (2006) (19)
- TCT-21 Use of IVUS Reduces Stent Thrombosis: Results from the Prospective, multicenter ADAPT-DES Study (2012) (19)
- Angiographic predictors of 2‐year stent thrombosis in patients receiving drug‐eluting stents: Insights from the ADAPT‐DES study (2017) (19)
- Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). (2013) (19)
- Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (2020) (19)
- Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. (2017) (18)
- Images in cardiovascular medicine. Myocardial infarction caused by occlusion of Cabrol conduit graft. (2005) (18)
- A Randomized, Intercontinental, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with de novo Coronary Artery Lesions BIOFLOW IV - Primary Outcome Target Vessel Failure at 12 Months. (2019) (17)
- Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study). (2017) (17)
- Long-Term Follow-Up of Attenuated Plaques in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy of the HORIZONS-AMI Trial (2012) (17)
- Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. (2017) (17)
- Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry (2019) (17)
- Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study). (2016) (17)
- Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study (2015) (17)
- Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. (2021) (16)
- Effect of Obesity on Coronary Atherosclerosis and Outcomes of Percutaneous Coronary Intervention: Grayscale and Virtual Histology Intravascular Ultrasound Substudy of Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (2014) (16)
- Prehospital versus periprocedural abciximab in ST -elevation myocardial infarction treated by percutaneous coronary intervention (2008) (16)
- Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). (2018) (16)
- Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). (2014) (15)
- Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI. (2015) (15)
- Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population: Analysis From the ADAPT-DES Registry (2018) (15)
- Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. (2021) (15)
- Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction (2013) (14)
- Impact of multiple complex plaques on short- and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial). (2014) (14)
- Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention (2020) (14)
- Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES. (2021) (14)
- Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation. (2017) (14)
- Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: Results from the HORIZONS‐AMI trial (2015) (14)
- Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy (2011) (13)
- Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study. (2018) (13)
- Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry (2016) (13)
- Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy. (2016) (13)
- Comparison of plaque morphology between peripheral and coronary artery disease (from the CLARITY and ADAPT-DES IVUS substudies) (2017) (13)
- Impact of advanced age on the safety and effectiveness of paclitaxel‐eluting stent implantation in patients with ST‐segment elevation myocardial infarction undergoing primary angioplasty (2013) (13)
- Intravascular ultrasound findings of stent fractures in patients with Sirolimus- and Paclitaxel-eluting stents. (2010) (13)
- Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Diabetic Patients With Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial (2011) (13)
- Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study. (2015) (13)
- Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery. (2013) (13)
- Usefulness of the Left Anterior Descending Coronary Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Inf (2015) (12)
- Coronary reperfusion and clinical outcomes after thrombus aspiration during primary percutaneous coronary intervention: Findings from the HORIZONS‐AMI trial (2013) (12)
- Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: an analysis of intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI). (2015) (12)
- Bleeding Severity After Percutaneous Coronary Intervention (2018) (12)
- 1022-79 Is early prehospital administration of abciximab superior to periprocedural therapy in patients with ST-segment elevation myocardial infarction and planned percutaneous coronary intervention? Early and late results from the randomized REOMOBILE pilot study (2004) (12)
- Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy. (2022) (11)
- Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry. (2019) (11)
- Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents) (2017) (11)
- Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE) (2014) (11)
- Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial. (2011) (10)
- Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry). (2017) (10)
- Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES (2015) (10)
- Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry. (2017) (10)
- Age-related effects of smoking on culprit lesion plaque vulnerability as assessed by grayscale and virtual histology–intravascular ultrasound (2015) (10)
- Serial intravascular ultrasound analysis of the impact of myocardial bridge on neointimal proliferation after coronary stenting in patients with acute myocardial infarction. (2010) (9)
- [Angina pectoris and ST-elevation after chemotherapy with 5-fluorouracil]. (2007) (9)
- Plaque shift and distal embolism in patients with acute myocardial infarction (2013) (9)
- Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial). (2012) (9)
- Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins? (2012) (9)
- [18-year old patient with anti-epileptic therapy and sudden cardiac death]. (2003) (9)
- Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial. (2021) (8)
- Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy. (2017) (8)
- Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES. (2021) (8)
- Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI. (2021) (8)
- Prediction of 1‐year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient‐level pooled analysis from three randomized trials (2016) (8)
- Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. (2021) (7)
- Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial (2017) (7)
- TCT-37 Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes (2013) (7)
- CRT-156 Two Year Safety And Clinical Performance Of The Drug Eluting Orsiro Stent In The Treatment Of Subjects With Single De Novo Coronary Artery Lesions (BIOFLOW-II) (2015) (7)
- Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial). (2013) (7)
- Cardiac Magnetic Resonance Imaging in Patients with Acute Ischemic Stroke and Elevated Troponin: A TRoponin ELevation in Acute Ischemic Stroke (TRELAS) Sub-Study (2019) (7)
- Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. (2019) (7)
- [Surgical angioplasty of the left main coronary artery. Evaluation and postoperative follow-up with intravascular ultrasound]. (2002) (7)
- Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study). (2019) (6)
- Percutaneous coronary intervention of lesions with in‐stent restenosis: A report from the ADAPT‐DES study (2017) (6)
- IMPACT OF POINT–OF–CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG–ELUTING STENTS: AN ADAPT–DES SUBSTUDY (2012) (6)
- Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study. (2019) (6)
- Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS (2019) (6)
- DOES PLATELET FUNCTION TESTING ADD SIGNIFICANT INCREMENTAL RISK STRATIFICATION TO UNSELECTED PATIENTS UNDERGOING DES IMPLANTATION? THE ADAPT-DES STUDY (2012) (6)
- Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study). (2019) (6)
- Impact of high on‐treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT‐DES substudy (2019) (6)
- Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy (2013) (6)
- Impact of high on‐aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug‐eluting stents (2018) (6)
- Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes. (2016) (6)
- Intra-individual head-to-head comparison of Sirolimus®- and Paclitaxel®-eluting stents for coronary revascularization. A randomized, multi-center trial. (2013) (5)
- Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate. (2021) (5)
- Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study. (2021) (5)
- Relation Between Renal Function and Coronary Plaque Morphology (from the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Virtual Histology-Intravascular Ultrasound Substudy). (2017) (5)
- Morphological changes and clinical impact of unstable plaques within untreated segments of acute myocardial infarction patients during a 3-year follow-up: an analysis from the HORIZONS-AMI trial (2015) (5)
- Sunday, 26 August 2012 (2012) (5)
- Cerebrovascular Events After a Primary Percutaneous Coronary Intervention Strategy for Acute ST-Segment– Elevation Myocardial Infarction: Analysis From the HORIZONS-AMI Trial (2015) (5)
- Percutaneous coronary intervention of bifurcation lesions and platelet reactivity. (2018) (5)
- Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI (2022) (4)
- Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention. (2022) (4)
- Antiplatelets and AntithrombinsTCT-152 Is There a Therapeutic Window For Platelet Responsiveness Among PCI Patients? Analysis from the ADAPT-DES Study (2013) (4)
- IMPACT OF GENDER ON PATTERNS OF DUAL ANTIPLATELET THERAPY CESSATION AND NON-ADHERENCE: ONE-YEAR RESULTS FROM THE PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS (PARIS), AN OBSERVATIONAL SINGLE-ARM STUDY (2013) (4)
- Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy (2017) (4)
- TCT-14 Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 12-month follow-up- BIOSOLVE-II and BIOSOLVE-III (2017) (4)
- Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (4)
- Relationship Between Stent Diameter, Platelet Reactivity, and Thrombotic Events After Percutaneous Coronary Artery Revascularization. (2019) (4)
- Abstract 20882: Predictors of Suboptimal TIMI Flow after Primary Angioplasty for Acute Myocardial Infarction: Results from the HORIZONS-AMI Trial (2010) (3)
- Postprocedural anticoagulation for specific therapeutic indications after revascularization for ST-segment elevation myocardial infarction (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial). (2014) (3)
- Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry (2019) (3)
- Impact of pre-procedural cardiopulmonary instability in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). (2014) (3)
- STENT EXPANSION MODELS TO PREDICT CLINICAL OUTCOME: AN IVUS SUBSTUDY FROM ADAPT-DES (2020) (3)
- PROGNOSTIC IMPACT OF STAGED VERSUS "ONE-TIME" MULTIVESSEL PCI IN ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: LONG-TERM ANALYSIS FROM THE HORIZONS-AMI TRIAL (2011) (3)
- Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial (2021) (3)
- BIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN STEMI PATIENTS UNDERGOING PRIMARY PCI: A POOLED ANALYSIS OF PATIENT-LEVEL DATA FROM THE HORIZONS-AMI AND EUROMAX TRIALS (2014) (3)
- TCT-188 Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries at 36-Month Follow-Up: BIOSOLVE-II and BIOSOLVE-III (2019) (3)
- Impact of an integrated treatment algorithm based on platelet function testing and clinical risk assessment: results of the TRIAGE Patients Undergoing Percutaneous Coronary Interventions To Improve Clinical Outcomes Through Optimal Platelet Inhibition study (2016) (3)
- IMPACT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER CORONARY ANGIOGRAPHY OR PERCUTANEOUS CORONARY INTERVENTION ON LONG-TERM OUTCOMES: A POOLED ANALYSIS FROM THE HORIZONS-AMI AND ACUITY TRIALS (2014) (3)
- Antiplatelets and AntithrombinsTCT-157 The Effect of Smoking Status on Platelet Reactivity and Long-Term Events after PCI. Does a Clopidogrel-related "Smoker's paradox" Exist? (2013) (2)
- Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention (2021) (2)
- TCT CONNECT-260 A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-Eluting Stent in the Treatment of Subjects With up to 2 De Novo Coronary Artery Lesions—BIOFLOW IV: 5-Year Clinical Results (2018) (2)
- Abstract 15919: Impact of Bivalirudin Therapy on Mortality in Patients With High Risk Features Undergoing PCI: A Patient-Level Pooled Analysis From the REPLACE-2, ACUITY and HORIZONS-AMI Trials (2011) (2)
- TCT-292 Reduced Bleeding Complications and Increased Event-free Survival With Femoral Vascular Closure Device Use and Bivalirudin in STEMI Patients Undergoing Primary Angioplasty in the HORIZONS-AMI Trial (2013) (2)
- WHITE BLOOD CELL COUNT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION IN THE CONTEMPORARY ERA: INSIGHTS FROM THE PARIS STUDY (2017) (2)
- COMPLIANCE WITH DUAL ANTIPLATELET THERAPY AND SUBSEQUENT ADVERSE EVENTS IN PATIENTS WITH STEMI UNDERGOING STENT IMPLANTATION: ANALYSIS FROM THE HORIZONS-AMI TRIAL (2010) (2)
- Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug‐Eluting Stents (ADAPT‐DES) study (2019) (2)
- Disturbance of the myocardial energy metabolism in A.SW/SNJ mice after viral infection (coxsackie virus B3) (1991) (2)
- TCT-173 Safety and Clinical Performance of the Drug Eluting Osiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) (2013) (2)
- ASSOCIATION OF STENT THROMBOSIS AND PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS: SIX MONTH RESULTS OF THE PARIS REGISTRY (2012) (2)
- TCT-63 Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III (2018) (2)
- TCT-467 Clinical Outcomes after Anterior ST-Elevation Myocardial Infarction According to LAD Lesion Location: The INFUSE-AMI Trial (2012) (2)
- Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention. (2019) (2)
- LONG-TERM CLINICAL IMPACT OF ACUTE STENT MALAPPOSITION: AN ADAPT-DES IVUS SUBSTUDY (2014) (2)
- MYOCARDIAL BRIDGING DOES NOT AFFECT ATHEROSCLEROSIS IN ADJACENT CORONARY ARTERY SEGMENTS: AN ADAPT–DES IVUS SUB–STUDY (2013) (1)
- Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. (2022) (1)
- IMPACT OF CHRONIC KIDNEY DISEASE ON LONG-TERM OUTCOMES IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION AND ALTERNATIVE ANTITHROMBOTIC TREATMENT STRATEGIES: A HORIZONS-AMI SUBSTUDY (2011) (1)
- INTRACORONARY ABCIXIMAB AND ASPIRATION THROMBECTOMY DURING PRIMARY PCI FOR ANTERIOR STEMI: ONE–YEAR RESULTS FROM THE RANDOMIZED INFUSE–AMI TRIAL (2013) (1)
- IMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: ANALYSIS FROM THE HORIZONS AMI TRIAL (2010) (1)
- CLINICAL UTILITY OF BIOMARKERS TO PREDICT STENT THROMBOSIS AFTER STEMI TREATED WITH DES: A HORIZONS-AMI SUBSTUDY WITH 3-YEAR FOLLOW-UP (2011) (1)
- IMPACT ON TWO-YEAR OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION COMPLEXITY AND PLATELET REACTIVITY AMONG PATIENTS WITH STABLE CORONARY ARTERY DISEASE: INSIGHT FROM THE ADAPT-DES STUDY (2015) (1)
- Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial (2022) (1)
- TCT-6 Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry (2013) (1)
- TCT-20 IVUS Predictors of Stent Thrombosis: Results From the Prospective, Multicenter ADAPT-DES Study (2012) (1)
- Abstract 17531: Two-Year Clinical Results Comparing Abciximab vs. Eptifibatide in Combination With 600mg vs. 300mg Clopidogrel Loading Dose in Patients With ST-Elevation Myocardial Infarction: Results from the HORIZONS-AMI Trial (2010) (1)
- LONG-TERM CLINICAL IMPACT OF CONTRAST-ASSOCIATED ACUTE KIDNEY INJURY FOLLOWING PCI AN ADAPT-DES SUB-STUDY (2021) (1)
- Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk (2022) (1)
- Increased surface expression of the vitronectin-receptor αvβ3 in human endothelial cells correlates with survival (1998) (1)
- Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry. (2020) (1)
- Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study). (2019) (1)
- Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study". (2016) (1)
- ETIOLOGY, TIMING AND IMPACT OF DUAL ANTIPLATELET THERAPY DISCONTINUATION AFTER DRUG-ELUTING STENT IMPLANTATION: INSIGHTS FROM THE ADAPT-DES STUDY (2016) (1)
- Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index. (2022) (1)
- [Chest pain, reduced physical activity, and polyserositis in a 35-year old patient with anticonvulsive medication]. (2006) (1)
- TCT-5 Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study (2013) (1)
- Abstract 4690: Impact of Thrombus Aspiration in Patients With STEMI Undergoing Primary PCI: Analysis From the HORIZONS-AMI Trial (2009) (1)
- Preadmission antiplatelet therapy and treatment effect of ticagrelor versus prasugrel in patients with acute coronary syndromes - a subgroup analysis of the ISAR-REACT 5 trial. (2022) (1)
- PLATELET REACTIVITY AND CLINICAL OUTCOMES AFTER CORONARY ARTERY IMPLANTATION OF DRUG-ELUTING STENTS IN SUBJECTS WITH PERIPHERAL ARTERIAL DISEASE: ANALYSIS FROM THE ADAPT-DES STUDY (2014) (1)
- Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial. (2023) (1)
- CLINICAL IMPACT OF ATTENUATED PLAQUE AFTER STENT IMPLANTATION: AN ADAPT-DES IVUS SUBSTUDY (2014) (1)
- TCT-657 Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation Of Elixir DESyneTM Novolimus-Eluting Coronary Stent System With Durable Polymer To Endeavor Zotarolimus-Eluting Coronary Stent System: 3-Year Clinical and 9-Month Angiographic And IVUS Results: EXCELLA II (2012) (1)
- TCT-57 Angiographic Reperfusion Indices Predict Infarct Size and Mortality: The INFUSE-AMI Trial (2012) (1)
- IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG DIABETIC AND NON-DIABETIC PATIENTS UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY (2012) (1)
- TCT-597 Two-Year Ischemic and Bleeding Outcomes After Coronary Intervention of Calcified vs. Non-Calcified Lesions Treated With Drug-eluting Stents: The ADAPT-DES Study (2015) (1)
- [Anticoagulant therapy for chronic cardiac diseases. Atrial fibrillation, valvular heart disease, congestive heart failure]. (2011) (1)
- TCT-479 The Increased Risk of Stent Thrombosis in Acute Coronary Syndromes is Confined to the First 30 days After PCI: Results from the Multicenter ADAPT-DES Study (2014) (1)
- TCT-516 Microvascular Obstruction Detected by MRI is a Predictor of Recovery from Myocardial Stunning: The INFUSE-AMI Trial (2012) (1)
- TCT-50 Angiographic Predictor of 2-Year Stent Thrombosis in Patients Receiving Drug-eluting Stents: Insights from the ADAPT-DES Study (2013) (1)
- CULPRIT LESION MORPHOLOGY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): THE HORIZONS-AMI TRIAL VH-IVUS SUBSTUDY (2011) (1)
- WHICH GLOMERULAR FILTRATION RATE EQUATION BEST PREDICTS POOR OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY PCI: RESULTS FROM THE HORIZONS-AMI STUDY (2012) (1)
- TCT-486 Additive And Independent Impact Of Chronic Kidney Disease And Diabetes Mellitus On High Platelet Reactivity And Adverse Events Following PCI: Results From The ADAPT-DES Registry (2014) (1)
- IMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC AND NON-DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: 3-YEAR RESULTS FROM THE HORIZONS AMI TRIAL (2011) (1)
- FREQUENCY, MECHANISMS AND IMPLICATIONS OF LATE PERI-STENT CONTRAST STAINING: ANALYSIS FROM THE HORIZONS-AMI TRIAL (2012) (1)
- Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes (2021) (1)
- IMPACT OF HEMODIALYSIS AND HIGH PLATELET REACTIVITY ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY (2014) (0)
- THE IMPACT OF LEFT VENTRICULAR FUNCTION ON MORTALITY IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION: ANALYSIS OF THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION (HORIZONS-AMI) STUDY (2010) (0)
- TCT-166 Predictors of Target Lesion Revascularization After Implantation of Second-Generation Drug-Eluting Stents in Randomized Trials and the “Real-World”: Analysis From Two Large Datasets (2018) (0)
- Impact of Routine Invasive Physiology at Time of Angiography in Patients With Multivessel Coronary Artery Disease on Reclassi fi cation of Revascularization Strategy (0)
- TCT-237 Outcomes After Successful PCI of Severely Calcified Lesions Using Rotational Atherectomy, Cutting Balloon, or Balloon Angioplasty only Before Second-Generation Drug-Eluting Stent Implantation. (2016) (0)
- Iconographies supplémentaires de l'article : Comparison of Outcomes of Patients With ST-Segment Elevation Myocardial Infarction With Versus Without Previous Coronary Artery Bypass Grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] (2013) (0)
- TCT-469 Frequency, Timing and Implications of Reinfarction after Primary Stenting in ST-Segment Elevation Myocardial Infarction: The HORIZONS-AMI trial (2012) (0)
- IMPACT OF HIGH DOSE ASPIRIN IN MEN VS. WOMEN AFTER ACUTE MYOCARDIAL INFARCTION: RESULTS FROM THE HORIZONS-AMI TRIAL (2012) (0)
- Relationship Between Platelet Reactivity and Culprit Lesion Morphology (0)
- TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry (2019) (0)
- TCT-596 Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights from the Serial IVUS analysis of the pivotal, prospective, multicentre, DESolve NX Trial (2013) (0)
- TCT-8 Impact of Aspirin Resistance on Outcomes after Coronary Events. (2016) (0)
- TCT-346 Race and Outcomes after PCI for ACS: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials (2013) (0)
- Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes (2022) (0)
- TCT-403 Impact of Bifurcation Lesion Treatment with DES on Clinical Outcomes: Results from the Prospective, Multicenter ADAPT-DES Study (2013) (0)
- P511Incidence and patterns of dual antiplatelet therapy cessation among patients with peripheral arterial disease after percutaneous coronary intervention: insights the PARIS registry (2017) (0)
- TCT-479 Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial (2012) (0)
- TCT-14: A Single Center, Real World Experience of Drug-Eluting Balloon Use in the Treatment of Instent Restenosis and Diffuse Coronary Artery Disease (2016) (0)
- TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES. (2016) (0)
- TCT-671 Relationship Between Plaque Morphologies And Clinical Presentation In The ADAPT-DES IVUS Substudy (2013) (0)
- PREDICTORS OF NEWLY IMPLANTED STENT EXPANSION IN IN-STENT RESTENOTIC LESIONS: AN ADAPT-DES IVUS SUBSTUDY (2015) (0)
- IMPACT OF EARLY AND LATE STENT MALAPPOSITION ON LONG-TERM CLINICAL OUTCOMES: THREE-YEAR FOLLOW-UP FROM THE HORIZONS-AMI IVUS SUBSTUDY (2012) (0)
- TCT-166 Correlates of High Platelet Reactivity on Clopidogrel in 8,533 Patients: An ADAPT-DES Substudy (2013) (0)
- TCT-47 Impact of Pre-procedural Cardiopulmonary Instability in Patients with Acute Myocardial Infarction Undergoing Primary PCI: Insights from the HORIZONS-AMI trial (2014) (0)
- DIFFERENTIAL IMPACT OF HIGH PLATELET REACTIVITY ON CLOPIDOGREL IN WOMEN AND MEN FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (PCI) WITH DES (2015) (0)
- TCT-3 Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial (2013) (0)
- INCIDENCE AND RISK FACTORS FOR CONTRAST-INDUCED NEPHROPATHY IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION: AN ANALYSIS FROM THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION TRIAL (HORIZONS-AMI) (2011) (0)
- TCT-540 Incidence, Predictors, and Impact of Post-Discharge Gastrointestinal Bleeding After Coronary Drug-Eluting Stents Implantation: The ADAPT-DES Study (2018) (0)
- MINIMUM STENT AREA IS AN INDEPENDENT PREDICTOR OF ANGIOGRAPHIC RESTENOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN STEMI: A HORIZONS-AMI IVUS SUBSTUDY (2011) (0)
- Interventional Cardiology Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction (2011) (0)
- TCT-518 Utility of Troponin and Creatine Kinase in Predicting Myocardial Infarct Size, Left Ventricular Dysfunction, and Clinical Outcomes After Acute Anterior Myocardial Infarction: The INFUSE-AMI Trial (2019) (0)
- TCT-64 Incidence, Predictors, and Impact of Post-discharge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention (2015) (0)
- TCT-733 Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After PCI: Analysis from the ADAPT-DES study (2017) (0)
- TCT-30 Clinical Predictors and Long-term Impact of Enzymatic Infarct Size After Primary PCI in STEMI: The HORIZONS-AMI Trial (2014) (0)
- Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial (2022) (0)
- TCT CONNECT-64 Impact of DAPT Cessation in High Bleeding-Risk Patients Undergoing PCI: Insights From the PARIS Registry (2020) (0)
- StarClose for 8 F: a multi-center safety and efficacy evaluation of the StarClose vascular closure device for arterial closure following 8-F sheath placement (2008) (0)
- COMPARISON OF LONG TERM CLINICAL PROGNOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO THE PRESENCE OF IN-HOSPITAL MAJOR BLEEDING EVENTS: 3 YEAR FOLLOW-UP RESULT OF HORIZONS-AMI (2011) (0)
- Access route and clinical outcomes after ticagrelor versus prasugrel in patients with acute coronary syndrome undergoing invasive treatment strategy. (2022) (0)
- TCT-72 PCI Lesion Morphology According to Chronic Statin Use: An ADAPT-DES IVUS Substudy (2013) (0)
- TCT-669 Differences in Culprit Lesion Plaque Stability between Males and Females: A VH-IVUS Analysis from the ADAPT-DES Study (2013) (0)
- Relation Between Renal Function and Coronary Plaque Morphology ( From the ADAPT-DES Virtual Histology-Intravascular Ultrasound Substudy ) Brief title : Coronary Plaque Morphology in CKD (2016) (0)
- Circulation: Cardiovascular Interventions (2022) (0)
- TCT-230 Impact of Delay to reperfusion on Infarct Size and Clinical Outcomes in Patients with STEMI: The INFUSE-AMI Trial (2013) (0)
- On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES (2022) (0)
- PLATELET REACTIVITY AND OUTCOMES AFTER PCI OF LESIONS WITH AND WITHOUT IN-STENT RESTENOSIS: THE ADAPT-DES STUDY (2017) (0)
- Antiplatelets and AntithrombinsTCT-156 Impact of Clopidogrel Hyporesponsiveness on Clinical Outcomes in Patients Receiving Drug-eluting Stents for Stable Coronary Disease in the ADAPT-DES Study (2013) (0)
- PROGNOSTIC UTILITY OF LEFT VENTRICULAR END-DIASTOLIC PRESSURE MEASUREMENT IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI: THE HORIZONS-AMI TRIAL (2011) (0)
- EFFECT OF HIGH PLATELET REACTIVITY ON ADVERSE EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION FOR LEFT MAIN CORONARY ARTERY DISEASE: THE ADAPT-DES STUDY (2020) (0)
- Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry. (2022) (0)
- P1744 Ratjadone is a potent inhibitor of vascular smooth muscle cell proliferation (2003) (0)
- TCT-667 Relationship Between Renal Function and Lesion Morphology: An ADAPT-DES VH-IVUS sub-study (2013) (0)
- CLOPIDOGREL WITH AND WITHOUT PROTON PUMP INHIBITOR USE: A PARIS REGISTRY ANALYSIS (2014) (0)
- Multi center, prospective, randomized, single blind, consecutive enrollment evaluation of the elixir desynetm novolimus-eluting coronary stent system with durable polymer compared to the endeavor zota (2013) (0)
- TCT-352 Proportion of Ischemic Risk After PCI Mediated by High Platelet Reactivity on Clopidogrel: Analysis From the ADAPT-DES Study. (2016) (0)
- TEMPORAL ASSOCIATIONS BETWEEN TIME AFTER PERCUTANEOUS CORONARY INTERVENTION, DUAL ANTIPLATELET THERAPY CESSATION AND STENT THROMBOSIS IN THE CONTEMPORARY PCI ERA: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- TCT-346 Relationship Between Peripheral Artery Disease and Coronary Plaque Morphology: An ADAPT-DES Intravascular Ultrasound Substudy (2014) (0)
- PLATELET REACTIVITY AND OUTCOMES AFTER PCI OF SAPHENOUS VEIN GRAFTS VERSUS NATIVE CORONARY ARTERIES: THE ADAPT-DES STUDY (2017) (0)
- TCT-109 Ischemic Outcomes after Coronary Intervention of Calcified Lesions with Drug-eluting Stent: Insight from ADAPT DES study (2014) (0)
- INCIDENCE, FEATURES, AND OUTCOMES OF EDGE DISSECTION AFTER DRUG-ELUTING STENT IMPLANTATION: AN ADAPT-DES IVUS SUB-STUDY (2014) (0)
- TCT-110 Incidence, predictors, and outcomes of DAPT disruption due to non-compliance versus bleeding after PCI: insights from the PARIS Registry (2018) (0)
- TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI (2022) (0)
- DISCHARGE MEDICATION USE IN PATIENTS WHO EXPERIENCE BLEEDING COMPLICATIONS AFTER PRIMARY PCI: ANALYSIS FROM HORIZONS-AMI (2011) (0)
- Early Contractile Failure (2005) (0)
- TCT-513 Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial (2012) (0)
- TCT-400 Platelet Reactivity and Risk of Stent Thrombosis After Coronary Drug-Eluting Stent Implantation in Patients Treated With Oral Anticoagulation: The ADAPT-DES Study (2019) (0)
- TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS. (2016) (0)
- TCT-546 Performance of the Dual AntiPlatelet Therapy (DAPT) Score in the ADAPT-DES Study. (2017) (0)
- TCT-366 Comparison of Plaque Morphology Between Peripheral and Coronary Artery Disease: Analysis from the CLARITY and ADAPT-DES IVUS Substudies (2015) (0)
- TCT-486 Relationship Between White Blood Cell Count and Final Infarct Size in Patients with ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Analysis from the INFUSE-AMI Trial (2012) (0)
- Abstract 4556: Incidence and Mechanisms of Acute and Late Stent Malapposition After Stent Implantation in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy of the HORIZONS-AMI Trial (2009) (0)
- TCT-732 Relationship Between Stent Diameter, Platelet Reactivity, and Adverse Events After PCI: Analysis from the ADAPT-DES study. (2017) (0)
- TCT-353 Underweight Status, Platelet Reactivity, and 2-Year Clinical Outcomes in Patients Undergoing PCI With DES: An ADAPT-DES Study Analysis. (2016) (0)
- TICAGRELOR MONOTHERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION. A PRESPECIFIED TWILIGHT SUBSTUDY (2021) (0)
- DUAL ANTIPLATELET THERAPY AND LONG-TERM CLINICAL OUTCOMES AFTER PRIMARY PCI: THE HORIZONS-AMI TRIAL (2012) (0)
- ASSOCIATIONS BETWEEN DIFFERENT MODES OF DAPT CESSATION AND MAJOR ADVERSE EVENTS AT 6 MONTHS AND BEYOND: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- IVUS PREDICTORS OF EARLY STENT THROMBOSIS AFTER PRIMARY PERCUTANEOUS INTERVENTION IN ACUTE MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY (2010) (0)
- TWO-YEAR CLINICAL OUTCOMES OF SECOND GENERATION VERSUS FIRST GENERATION CORONARY DRUG-ELUTING STENTS: AN ANALYSIS FROM ADAPT-DES (2014) (0)
- DOES CALCIUM BURDEN IMPACT ON CULPRIT LESION MORPHOLOGY AND CLINICAL (2015) (0)
- TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention. (2016) (0)
- DUAL ANTIPLATELET THERAPY (DAPT) CESSATION AND CARDIOVASCULAR RISK IN RELATION TO AGE: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY (2019) (0)
- Prospective, multi-center evaluation of the desolve NX novolimus-eluting bioresorbable coronary scaffold: principal clinical and imaging endpoints (2013) (0)
- MYOCARDIAL ISCHEMIA AND INFARCTION RELATIONSHIP BETWEEN BIOMARKERS AND SUBSEQUENT MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY (2011) (0)
- CLINICAL IMPACT OF TISSUE PROTRUSION AFTER STENT IMPLANTATION: AN ADAPT-DES IVUS SUBSTUDY (2014) (0)
- Deteriorated contractility and disturbance of the myocardial energy metabolism in A.CA/SNJ mice following immunisation with the ADP/ATP carrier (1991) (0)
- PATIENTS ADMITTED WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND A NORMAL OR NEAR NORMAL CORONARY ANGIOGRAM HAVE A FAVORABLE PROGNOSIS: ANALYSIS FROM HORIZONS-AMI TRIAL (2010) (0)
- IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL (2011) (0)
- TCT-127 Incidence, Predictors, and Prognostic Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention (2014) (0)
- TCT-596 Pantera Lux Drug Coated Balloon: Twelve-Month Results On The Diabetics Subgroup Of The International DELUX Registry (2012) (0)
- TCT-23 Etiology, Frequency, and Clinical Outcomes of Post-procedural Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-up From the ADAPT-DES Study (2014) (0)
- TCT-123 Incidence and Impact of Acute Kidney Injury in Patients with Acute Coronary Syndromes Treated with CABG: Insights from ACUITY/HORIZONS-AMI (2014) (0)
- TCT-217 Predictors of Dyspnea in Patients Receiving Ticagrelor After PCI: Insights From the Twilight Trial (2021) (0)
- TCT-205 Incidence and clinical outcomes associated with DAPT discontinuation in complex PCI patients: From the PARIS registry. (2016) (0)
- Clinical Outcomes Following Stent Thrombosis Occurring In-Hospital Versus Out-of-Hospital (2012) (0)
- Wednesday, 29 August 2012 (2012) (0)
- TCT-296 Impact of Baseline Positive Coronary Artery Remodeling on 2-year Outcomes after IVUS-guided PCI: The ADAPT-DES IVUS Sub-Study (2017) (0)
- Angiography and QCA (TCT-84 to TCT-93)TCT-87 Frequency And Impact Of Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention In Women Compared To Men: Pooled Analysis From The ACUITY And HORIZONS-AMI Trials (2014) (0)
- IMPACT OF BIVALIRUDIN PROCEDURAL ANTICOAGULATION IN PATIENTS WITH DIABETES MELLITUS AND ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: 3-YEAR RESULTS FROM THE HORIZONS AMI TRIAL (2011) (0)
- IMPACT OF BODY MASS INDEX ON MAJOR BLEEDING AFTER PCI: ONE-YEAR RESULTS FROM THE MULTICENTER PROSPECTIVE PARIS REGISTRY (2013) (0)
- TCT-483 Impact of HbA1c Levels on Residual Platelet Reactivity and Outcomes after Coronary Drug-Eluting Stents: The ADAPT-DES study (2014) (0)
- Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents : Primary Endpoint Results from the Dual Antiplatelet Therapy Study (2014) (0)
- TCT-155 The Interaction Between Clopidogrel and Calcium Channel Blockers on Platelet Reactivity and Long-Term Events after PCI (2013) (0)
- Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes. (2021) (0)
- TCT-53 Abstract Withdrawn (2022) (0)
- IMPACT OF SMOKING AND ALTERNATIVE ANTITHROMBOTIC STRATEGIES ON OUTCOMES OF PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: ANALYSIS FROM THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION (HORIZONS-AMI) TRIAL (2010) (0)
- TCT-225 Impact of Age on the Disruption of Dual Antiplatelet Therapy: Analysis from the PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented) Patients Registry (2015) (0)
- OralBleeding and the Hazards of AnticoagulationTCT-89 Tradeoff between Myocardial Infarction and Bleeding in Relation to Bleeding Risk: insights from PARIS registry (2017) (0)
- LACK OF ASSOCIATION BETWEEN ON–TREATMENT PLATELET REACTIVITY AND ISCHEMIC OUTCOMES IN DIABETIC PATIENTS: ONE YEAR RESULTS OF THE ADAPT–DES STUDY (2013) (0)
- TRANSRADIAL VS. TRANSFEMORAL APPROACH FOR PRIMARY ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION: ANALYSIS FROM THE HORIZONS-AMI TRIAL. (2010) (0)
- FREQUENCY AND IMPACT OF SINGLE VERSUS DUAL ANTIPLATELET CESSATION ON ADVERSE CARDIAC EVENTS: RESULTS FROM THE PARIS REGISTRY (2013) (0)
- PREDICTORS OF DUAL ANTIPLATELET THERAPY NON-ADHERENCE AFTER PCI: ONE-YEAR INSIGHTS FROM THE PARIS REGISTRY (2013) (0)
- DYNAMIC NATURE OF NON-CULPRIT CORONARY ARTERY LESION MORPHOLOGY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS: A SERIAL VIRTUAL HISTOLOGY-INTRAVASCULAR ULTRASOUND ANALYSIS FROM THE HORIZONS-ACUTE MYOCARDIAL INFARCTION TRIAL (2011) (0)
- Abstract 18402: Impact of the Use of Different Bleeding Scales on the Rate of 6-Month Bleeding After PCI: Results from the PARIS Registry (2012) (0)
- Abstract 16705: Lower Education Level is Associated with Non-Adherence to Dual Antiplatelet Therapy After PCI: 6-Month Results from PARIS (2012) (0)
- RELATIONSHIP BETWEEN PLATELET REACTIVITY AND CULPRIT AND NON–CULPRIT LESION MORPHOLOGY: THE ADAPT–DES IVUS SUBSTUDY (2013) (0)
- TCT-222 Reperfusion Success, Infarct Size and Clinical Outcomes in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Anterior Myocardial Infarction (2013) (0)
- ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND MACE DUE TO STOPPING ONE OR BOTH DRUGS: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- CORRELATION AND PROGNOSTIC UTILITY BETWEEN LEFT VENTRICULAR END-DIASTOLIC PRESSURE AND LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI: THE HORIZONS-AMI TRIAL (2011) (0)
- IMPACT OF POSITIVE AND NEGATIVE CORONARY REMODELING ON CULPRIT LESION MORPHOMETRY: THE ADAPT–DES IVUS SUBSTUDY (2013) (0)
- TCT-664 Impact of Obesity on Coronary Atherosclerosis Assessed by Grayscale and Virtual histology Intravascular Ultrasound (2013) (0)
- RELATIONSHIP BETWEEN BIOMARKERS AND SUBSEQUENT ADVERSE ISCHEMIC AND BLEEDING EVENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY (2011) (0)
- Moderated Poster Session 3 (2012) (0)
- TCT-1 Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES (2013) (0)
- Animal Model Mouse Model of Angiogenesis (2007) (0)
- CRT-157 Does the Drug Eluting Stent Implantation Decrease with Age Increase in Elderly Population? (2015) (0)
- TCT-18 Clinical and Procedural Predictors and Consequences of Stent Thrombosis Following Drug-eluting Stents for Acute Coronary Syndromes: Results From the ADAPT-DES Study (2013) (0)
- RISKS AND BENEFITS OF POST–PROCEDURAL ANTICOAGULATION IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI: ANALYSIS FROM THE HORIZONS–AMI TRIAL (2013) (0)
- Sex Differences in the Progression of Aortic€Stenosis and Prognostic Implication (0)
- Long-Term Follow-Up of Attenuated Plaques in Patients With Acute Myocardial Infarction (2012) (0)
- LAD WRAPPING AROUND THE LV APEX PREDICTS ADVERSE CARDIAC OUTCOMES IN ANTERIOR STEMI- A HORIZONS-AMI SUB-STUDY (2014) (0)
- TCT-420 Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention (2019) (0)
- Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (0)
- INCIDENCE, PATTERNS AND ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND RISK FOR ADVERSE EVENTS IN HIGH-RISK PATIENTS: INSIGHTS FROM THE PARIS REGISTRY (2018) (0)
- IMPACT OF PACLITAXEL-ELUTING STENTS IN PATIENTS WITH ANTERIOR MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY COMPARED WITH BARE METAL STENTS: ANALYSIS FROM THE HORIZONS AMI TRIAL (2010) (0)
- TCT-19 Predictors of Target Vessel Revascularization after Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction: Lessons from HORIZONS-AMI (2014) (0)
- IMPACT OF SMALL DEVICE USE IN THE PROXIMAL LAD VERSUS OTHER CORONARY SEGMENTS ON LONG-TERM CLINICAL OUTCOMES: AN ADAPT-DES SUB-ANALYSIS (2018) (0)
- TCT-7 Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis From ADAPT-DES. (2016) (0)
- TCT-211 Incidence and Impact of Dual Antiplatelet Therapy Cessation on Clinical Outcomes in Patients with Renal Dysfunction: Insights from the PARIS Registry. (2016) (0)
- TCT-595 Pantera Lux Drug Coated Balloon: Twelve-Month Results On 1'064 Patients Of The International DELUX Registry (2012) (0)
- Abstract 4368: Impact of Baseline Thrombus on Acute Tissue Protrusion and Late Neointimal Formation After Stent Implantation in Acute Myocardial Infarction: An Intravascular Ultrasound Substudy From the HORIZONS-AMI Trial (2009) (0)
- Errata (1918) (0)
- TCT-597 Predictors of Stent Expansion After Drug-eluting Stents: An ADAPT-DES IVUS substudy (2013) (0)
- Adverse Cardiac Events , and Infarct Size In Anterior Myocardial Infarction : An Analysis of INFUSE-AMI RCT # NCT 00976521 (2014) (0)
- Abstract 4757: Attenuated Plaque Identified by Intravascular Ultrasound Predicts No-Reflow After Stenting in Acute Myocardial Infarction: The HORIZONS-AMI Trial (2009) (0)
- Abstract 13942: Do Geographic Trends in Aspirin Discharge Dose Alter Outcomes After STEMI and Primary PCI: Results From the HORIZONS-AMI Trial (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bernhard Witzenbichler?
Bernhard Witzenbichler is affiliated with the following schools:
